跳转至内容
Merck
CN

Optimization of a series of multi-isoform PI3 kinase inhibitors.

Bioorganic & medicinal chemistry letters (2008-09-09)
Benjamin Perry, Rebekah Beevers, Gavin Bennett, George Buckley, Tom Crabbe, Lewis Gowers, Lynwen James, Kerry Jenkins, Chris Lock, Verity Sabin, Sara Wright
摘要

Optimization of the cellular and pharmacological activity of a novel series of PI3 kinase inhibitors targeting multiple isoforms is described.

材料
货号
品牌
产品描述

Sigma-Aldrich
4-吡唑硼酸频哪醇酯, 97%